Skip to content

Application of Transcutaneous Acupoint Electrical Stimulation in Video-Assisted Thoracoscopic Surgery for Perioperative Analgesia

Application of Transcutaneous Acupoint Electrical Stimulation in Video-Assisted Thoracoscopic Surgery for Perioperative Analgesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079540
Enrollment
Unknown
Registered
2024-01-05
Start date
2024-01-11
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lung cancer

Interventions

TEAS group:Transcutaneous electrical acupoint stimulation in the perioperative period
control group:Transcutaneous electrical acupoint sham-stimulation in the perioperative period

Sponsors

Cancer Hospital Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients undergoing VATS lung resection for pulmonary nodules or tumors, aged between 18 and 65 years. 2. ASA classification of 1-2. 3. Preoperative lung function tests indicating tolerance for single-lung ventilation, with FEV1 = 70% of predicted value and no ventilation impairment. 4. No previous chest surgery. 5. Absence of severe systemic diseases or poorly controlled chronic diseases involving the heart, liver, kidneys, nervous system, etc. 6. Education level of at least primary school, with the ability to understand the NRS scoring system and related questionnaire assessments. 7. Signed informed consent;

Exclusion criteria

Exclusion criteria: 1. History of chronic pain, recent use of analgesics or history of opioid or alcohol abuse; 2. Trauma, nerve damage, infection or unsuitable for TEAS as judged by researchers around corresponding TEAS acupoints; 3. Received TEAS or acupuncture treatment in the past 1 month; 4. History of severe cardiac arrhythmia; 5. Cardiac pacemakers or other implanted electrostimulation devices; 6. Intolerant to TEAS treatment; 7. Epilepsy or other severe neurological or psychiatric disorders; 8. Participated in other clinical trials in the past 1 month.

Design outcomes

Primary

MeasureTime frame
NRS score during coughing;

Secondary

MeasureTime frame
NRS score at rest and during daily works;NRS score during coughing;Maximum NRS score within 24 hours after surgery;Chronic postoperative pain GPCS scale;Sufentanil dosage used in PACU;postoperative rescue analgesics;Total PCA drug dosage, number and effective number of press;Pulmonary complications;Gastrointestinal dysfunction;Cognitive dysfunction;Other perioperative complications;Scale assessments (SF-12 QOL scale, SAS anxiety scale);

Countries

China

Contacts

Public ContactZheng Hui

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science and Peking Union Medical College

zhoubowengary@163.com+86 131 4127 3301

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026